HRS-1893 (also known as BHB-1893) is a selective, small-molecule, cardiac myosin inhibitor engineered to improve heart performance in patients with HCM. By modulating cardiac contractility, HRS-1893 ...

Braveheart Bio Inc. reported positive results from an open-label randomized phase II dose-ranging study of BHB-1893 (HRS-1893) in obstructive hypertrophic cardiomyopathy. Results presented at the ...

Add Yahoo as a preferred source to see more of our stories on Google. Actor Jim Caviezel gave a speech this weekend at a QAnon conference in Las Vegas, and while at least one of his former industry ...

Braveheart Bio, a clinical-stage biotechnology company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and related cardiovascular conditions, today announced the ...

If you're going ... •The ninth annual Braveheart Testimonial Dinner is scheduled for April 19 at the New Englander Banquet Center, 3009 Wilmington Road. Doors open at 5 p.m., and dinner ...

This often parodied quote from Mel Gibson’s William Wallace in the film Braveheart is something of a contradiction, and yet its sentiment is easy to understand. Nothing gets our hackles up more than ...

Mel Gibson in a scene from Oscar-winning film, 'Braveheart.' “Braveheart was my first movie, and I was completely unknown,” recalled the film’s writer, Randall Wallace. “The striking thing about the ...